In his Tuesday address to Congress, President Trump listed U.S.-funded programs that he considers an "appalling waste" — ...

More than half of the people living with HIV in Philadelphia are 50 and older, and they face greater risk of frailty and impairment.

The possibility of ending the HIV epidemic in Europe is more tangible than ever, but the actions we take now will determine ...

The US President's Emergency Plan for AIDS Relief has been a cornerstone of global HIV/AIDS prevention, care and treatment ...

The FDA has accepted under Priority Review the NDA for lenacapavir for the prevention of HIV as pre-exposure prophylaxis.

We can now prevent HIV transmissions and deaths — progress impossible without investments from the U.S. government ...

Foster City: Gilead Sciences, Inc. has announced that the U.S. Food and Drug Administration (FDA) has accepted its New Drug Application (NDA) submissions for lenacapavir-the company’s twice-yearly ...

new treatments can effectively suppress HIV, prevent transmission and allow long and healthy lives. While fewer people acquired HIV in 2023 across the world than at any time since the mid 1990s ...

“Today, we are one step closer to introducing the first-ever twice-yearly HIV prevention choice that could, if approved, help transform the landscape for individuals who need or want additional ...

THE U.S. Food and Drug Administration (FDA) has accepted a New Drug Application (NDA) for the first-ever twice-yearly injectable HIV prevention therapy. This investigational treatment, a long-acting ...